A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Clinical trial NCT01962987 · COMPLETED

Trial details

NCT number: NCT01962987
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2013-03-01
Primary completion: 2013-09-01
Enrollment: 476

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.